Effectiveness of an Inactivated Quadrivalent Influenza Vaccine in Children and Pregnant Women in Rural Bangladesh: A Phase IV Double-Blind, Cluster-Randomized Trial.
Abstract
Objective
Influenza remains a major cause of morbidity and mortality in low- and middle-income countries (LMICs). This Phase IV, double-blind, cluster-randomized trial evaluated the Vaccine Effectiveness (VE) of a quadrivalent inactivated influenza vaccine (QIV) among children under 5 and pregnant women in rural Bangladesh.
Methods
Twenty villages in Matlab, Bangladesh were randomized 1:1 to receive either QIV or inactivated poliovirus vaccine (IPV) as control. Vaccination occurred between April and June 2021, with follow-up surveillance through December 2022. Seventy-five pregnant women (28-34 weeks of gestation) and 2,736 children aged 6-59 months received one dose or two doses at 4-week interval, respectively, of the assigned vaccine. The participants and villagers having influenza-like illnesses (ILI) were monitored and specimens were tested for influenza using real-time Reverse Transcriptase PCR.
Results
QIV provided strong protection during the influenza B/Victoria wave (April-August 2021), with adjusted total vaccine effectiveness (VE) of 77.4% (95% CI: 47.4-90.3) in children and 77.9% (95% CI: 48.9-90.5) among all participants. Among pregnant women, only two laboratory-confirmed influenza cases occurred, both in the control group; the small number of events precluded a reliable assessment of vaccine effectiveness in this subgroup. VE was low and non-significant during the influenza A/H1N1 wave, and negative during the influenza A/H3N2 wave. No indirect protection was observed among unvaccinated villagers.
Conclusions
QIV was effective against influenza B/Victoria and reduced ILI cases during the influenza B wave. Findings support including influenza vaccination for children in national programs.